Last 12 months
Inside the activity.
0 purchase rows · 33 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 4 |
| Mar 2026 | 0 | 5 |
| Apr 2026 | 0 | 2 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 3 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 5 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 26, 2017 Filed Feb 27, 2017 22:41 UTC |
Ehrich ElliotEVP, R&D & CMO, Alkermes, Inc.
|
Tax withholdingOrdinary Shares | 1,765 | $52.98 | $93,509.70 |
DisclosureSEC source: 0001127602-17-008683 · form4.xml · nonDerivative · entry 2 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,042 Read SEC document |
| February 26, 2017 Filed Feb 27, 2017 22:41 UTC |
Ehrich ElliotEVP, R&D & CMO, Alkermes, Inc.
|
Exercise / conversionOrdinary Shares | 3,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-008683 · form4.xml · nonDerivative · entry 1 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,807 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 26, 2017 Filed Feb 27, 2017 22:35 UTC |
Cooke ShanePresident, Alkermes plc
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 4,425 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-008679 · form4.xml · derivative · entry 3 Cooke Shane · CIK 0001524823 · President, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,850 Underlying: Ordinary Shares · 4,425 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/26/2016. F1 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/26/2016. Read SEC document |
| February 26, 2017 Filed Feb 27, 2017 22:35 UTC |
Cooke ShanePresident, Alkermes plc
|
Tax withholdingOrdinary Shares | 2,301 | $52.98 | $121,906.98 |
DisclosureSEC source: 0001127602-17-008679 · form4.xml · nonDerivative · entry 2 Cooke Shane · CIK 0001524823 · President, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 66,068 Read SEC document |
| February 26, 2017 Filed Feb 27, 2017 22:35 UTC |
Cooke ShanePresident, Alkermes plc
|
Exercise / conversionOrdinary Shares | 4,425 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-008679 · form4.xml · nonDerivative · entry 1 Cooke Shane · CIK 0001524823 · President, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,369 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 26, 2017 Filed Feb 27, 2017 22:34 UTC |
Brown Iain MichaelSVP Finance & CAO, Alks Inc.
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 1,100 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-008678 · form4.xml · derivative · entry 3 Brown Iain Michael · CIK 0001643456 · SVP Finance & CAO, Alks Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,200 Underlying: Ordinary Shares · 1,100 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/26/2016. F1 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/26/2016. Read SEC document |
| February 26, 2017 Filed Feb 27, 2017 22:34 UTC |
Brown Iain MichaelSVP Finance & CAO, Alks Inc.
|
Tax withholdingOrdinary Shares | 357 | $52.98 | $18,913.86 |
DisclosureSEC source: 0001127602-17-008678 · form4.xml · nonDerivative · entry 2 Brown Iain Michael · CIK 0001643456 · SVP Finance & CAO, Alks Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,050 Read SEC document |
| February 26, 2017 Filed Feb 27, 2017 22:34 UTC |
Brown Iain MichaelSVP Finance & CAO, Alks Inc.
|
Exercise / conversionOrdinary Shares | 1,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-008678 · form4.xml · nonDerivative · entry 1 Brown Iain Michael · CIK 0001643456 · SVP Finance & CAO, Alks Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,407 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 26, 2017 Filed Feb 27, 2017 22:32 UTC |
BIBERSTEIN KATHRYN LEVP/CAO/CCO Alks Inc; Sec ALKS
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 3,750 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-008675 · form4.xml · derivative · entry 5 BIBERSTEIN KATHRYN L · CIK 0001235595 · EVP/CAO/CCO Alks Inc; Sec ALKS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Ordinary Shares · 3,750 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/26/2016. F3 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/26/2016. Read SEC document |
| February 26, 2017 Filed Feb 27, 2017 22:32 UTC |
BIBERSTEIN KATHRYN LEVP/CAO/CCO Alks Inc; Sec ALKS
|
Tax withholdingOrdinary Shares | 1,217 | $52.98 | $64,476.66 |
DisclosureSEC source: 0001127602-17-008675 · form4.xml · nonDerivative · entry 2 BIBERSTEIN KATHRYN L · CIK 0001235595 · EVP/CAO/CCO Alks Inc; Sec ALKS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,220 Read SEC document |
| February 26, 2017 Filed Feb 27, 2017 22:32 UTC |
BIBERSTEIN KATHRYN LEVP/CAO/CCO Alks Inc; Sec ALKS
|
Exercise / conversionOrdinary Shares | 3,750 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-008675 · form4.xml · nonDerivative · entry 1 BIBERSTEIN KATHRYN L · CIK 0001235595 · EVP/CAO/CCO Alks Inc; Sec ALKS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,437 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 21, 2017 Filed Feb 21, 2017 23:03 UTC |
Ehrich ElliotEVP, R&D & CMO, Alkermes, Inc.
|
GiftOrdinary Shares | 600 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-007489 · form4.xml · nonDerivative · entry 1 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,057 Read SEC document |
| February 17, 2017 Filed Feb 21, 2017 22:55 UTC |
POPS RICHARD FDirector · Director and CEO, Alkermes plc
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 200,000 | $0.00 Strike: $54.57 | $0.00 |
DisclosureSEC source: 0001127602-17-007477 · form4.xml · derivative · entry 2 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 200,000 Underlying: Ordinary Shares · 200,000 shares Expires 2027-02-17 F2 · derivative.exercise_date: Shares subject to the stock option award vest in four equal annual installments commencing on 2/17/18. Read SEC document |
| February 17, 2017 Filed Feb 21, 2017 22:55 UTC |
POPS RICHARD FDirector · Director and CEO, Alkermes plc
|
GrantRestricted Stock Unit Award · Derivative | 35,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-007477 · form4.xml · derivative · entry 1 POPS RICHARD F · CIK 0001126490 · Director · Director and CEO, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Underlying: Ordinary Shares · 35,000 shares Expires not disclosed F1 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/17/18. F1 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/17/18. Read SEC document |
| February 17, 2017 Filed Feb 21, 2017 22:48 UTC |
Gaffin David JosephSVP, CLO, Alkermes, Inc.
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $54.57 | $0.00 |
DisclosureSEC source: 0001127602-17-007473 · form4.xml · derivative · entry 2 Gaffin David Joseph · CIK 0001675905 · SVP, CLO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Ordinary Shares · 40,000 shares Expires 2027-02-17 F2 · derivative.exercise_date: Shares subject to the stock option award vest in four equal annual installments commencing on 2/17/18. Read SEC document |
| February 17, 2017 Filed Feb 21, 2017 22:48 UTC |
Gaffin David JosephSVP, CLO, Alkermes, Inc.
|
GrantRestricted Stock Unit Award · Derivative | 10,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-007473 · form4.xml · derivative · entry 1 Gaffin David Joseph · CIK 0001675905 · SVP, CLO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Ordinary Shares · 10,000 shares Expires not disclosed F1 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/17/18. F1 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/17/18. Read SEC document |
| February 17, 2017 Filed Feb 21, 2017 23:03 UTC |
Ehrich ElliotEVP, R&D & CMO, Alkermes, Inc.
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 65,000 | $0.00 Strike: $54.57 | $0.00 |
DisclosureSEC source: 0001127602-17-007489 · form4.xml · derivative · entry 3 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,000 Underlying: Ordinary Shares · 65,000 shares Expires 2027-02-17 F2 · derivative.exercise_date: Shares subject to the stock option award vest in four equal annual installments commencing on 2/17/18. Read SEC document |
| February 17, 2017 Filed Feb 21, 2017 23:03 UTC |
Ehrich ElliotEVP, R&D & CMO, Alkermes, Inc.
|
GrantRestricted Stock Unit Award · Derivative | 15,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-007489 · form4.xml · derivative · entry 2 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Ordinary Shares · 15,000 shares Expires not disclosed F1 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/17/18. F1 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/17/18. Read SEC document |
| February 17, 2017 Filed Feb 21, 2017 22:59 UTC |
FRATES JAMES MSVP, Alks Inc; CFO ALKS
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $54.57 | $0.00 |
DisclosureSEC source: 0001127602-17-007482 · form4.xml · derivative · entry 2 FRATES JAMES M · CIK 0001235598 · SVP, Alks Inc; CFO ALKS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Ordinary Shares · 50,000 shares Expires 2027-02-17 F2 · derivative.exercise_date: Shares subject to the stock option award vest in four equal annual installments commencing on 2/17/18. Read SEC document |
| February 17, 2017 Filed Feb 21, 2017 22:59 UTC |
FRATES JAMES MSVP, Alks Inc; CFO ALKS
|
GrantRestricted Stock Unit Award · Derivative | 12,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-007482 · form4.xml · derivative · entry 1 FRATES JAMES M · CIK 0001235598 · SVP, Alks Inc; CFO ALKS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Ordinary Shares · 12,000 shares Expires not disclosed F1 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/17/18. F1 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/17/18. Read SEC document |
| February 17, 2017 Filed Feb 21, 2017 22:56 UTC |
Stejbach MarkSVP/Chief Comm Off, Alks Inc
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $54.57 | $0.00 |
DisclosureSEC source: 0001127602-17-007479 · form4.xml · derivative · entry 2 Stejbach Mark · CIK 0001487937 · SVP/Chief Comm Off, Alks Inc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Ordinary Shares · 50,000 shares Expires 2027-02-17 F2 · derivative.exercise_date: Shares subject to the stock option award vest in four equal annual installments commencing on 2/17/18. Read SEC document |
| February 17, 2017 Filed Feb 21, 2017 22:56 UTC |
Stejbach MarkSVP/Chief Comm Off, Alks Inc
|
GrantRestricted Stock Unit Award · Derivative | 12,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-007479 · form4.xml · derivative · entry 1 Stejbach Mark · CIK 0001487937 · SVP/Chief Comm Off, Alks Inc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Ordinary Shares · 12,000 shares Expires not disclosed F1 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/17/18. F1 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/17/18. Read SEC document |
| February 17, 2017 Filed Feb 21, 2017 22:50 UTC |
LANDINE MICHAEL JSVP, Corp Dev., Alkermes, Inc.
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $54.57 | $0.00 |
DisclosureSEC source: 0001127602-17-007474 · form4.xml · derivative · entry 2 LANDINE MICHAEL J · CIK 0001235600 · SVP, Corp Dev., Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Ordinary Shares · 50,000 shares Expires 2027-02-17 F2 · derivative.exercise_date: Shares subject to the stock option award vest in four equal annual installments commencing on 2/17/18. Read SEC document |
| February 17, 2017 Filed Feb 21, 2017 22:50 UTC |
LANDINE MICHAEL JSVP, Corp Dev., Alkermes, Inc.
|
GrantRestricted Stock Unit Award · Derivative | 12,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-007474 · form4.xml · derivative · entry 1 LANDINE MICHAEL J · CIK 0001235600 · SVP, Corp Dev., Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Ordinary Shares · 12,000 shares Expires not disclosed F1 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/17/18. F1 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/17/18. Read SEC document |
| February 17, 2017 Filed Feb 21, 2017 22:33 UTC |
Cooke ShanePresident, Alkermes plc
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 85,000 | $0.00 Strike: $54.57 | $0.00 |
DisclosureSEC source: 0001127602-17-007447 · form4.xml · derivative · entry 2 Cooke Shane · CIK 0001524823 · President, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,000 Underlying: Ordinary Shares · 85,000 shares Expires 2027-02-17 F2 · derivative.exercise_date: Shares subject to the stock option award vest in four equal annual installments commencing on 2/17/18. Read SEC document |
| February 17, 2017 Filed Feb 21, 2017 22:33 UTC |
Cooke ShanePresident, Alkermes plc
|
GrantRestricted Stock Unit Award · Derivative | 18,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-007447 · form4.xml · derivative · entry 1 Cooke Shane · CIK 0001524823 · President, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,000 Underlying: Ordinary Shares · 18,000 shares Expires not disclosed F1 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/17/18. F1 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/17/18. Read SEC document |
| February 17, 2017 Filed Feb 21, 2017 22:27 UTC |
Brown Iain MichaelSVP Finance & CAO, Alks Inc.
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 40,000 | $0.00 Strike: $54.57 | $0.00 |
DisclosureSEC source: 0001127602-17-007440 · form4.xml · derivative · entry 2 Brown Iain Michael · CIK 0001643456 · SVP Finance & CAO, Alks Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Ordinary Shares · 40,000 shares Expires 2027-02-17 F2 · derivative.exercise_date: Shares subject to the stock option award vest in four equal annual installments commencing on 2/17/18. Read SEC document |
| February 17, 2017 Filed Feb 21, 2017 22:27 UTC |
Brown Iain MichaelSVP Finance & CAO, Alks Inc.
|
GrantRestricted Stock Unit Award · Derivative | 10,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-007440 · form4.xml · derivative · entry 1 Brown Iain Michael · CIK 0001643456 · SVP Finance & CAO, Alks Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,000 Underlying: Ordinary Shares · 10,000 shares Expires not disclosed F1 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/17/18. F1 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/17/18. Read SEC document |
| February 17, 2017 Filed Feb 21, 2017 22:26 UTC |
BIBERSTEIN KATHRYN LEVP/CAO/CCO Alks Inc; Sec ALKS
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 65,000 | $0.00 Strike: $54.57 | $0.00 |
DisclosureSEC source: 0001127602-17-007439 · form4.xml · derivative · entry 2 BIBERSTEIN KATHRYN L · CIK 0001235595 · EVP/CAO/CCO Alks Inc; Sec ALKS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,000 Underlying: Ordinary Shares · 65,000 shares Expires 2027-02-17 F2 · derivative.exercise_date: Shares subject to the stock option award vest in four equal annual installments commencing on 2/17/18. Read SEC document |
| February 17, 2017 Filed Feb 21, 2017 22:26 UTC |
BIBERSTEIN KATHRYN LEVP/CAO/CCO Alks Inc; Sec ALKS
|
GrantRestricted Stock Unit Award · Derivative | 15,000 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001127602-17-007439 · form4.xml · derivative · entry 1 BIBERSTEIN KATHRYN L · CIK 0001235595 · EVP/CAO/CCO Alks Inc; Sec ALKS 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Ordinary Shares · 15,000 shares Expires not disclosed F1 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/17/18. F1 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in equal annual installments over a four year period, commencing on 2/17/18. Read SEC document |
| February 16, 2017 Filed Feb 16, 2017 22:56 UTC |
Ehrich ElliotEVP, R&D & CMO, Alkermes, Inc.
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $16.55 | $0.00 |
DisclosureSEC source: 0001127602-17-006681 · form4.xml · derivative · entry 5 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,801 Underlying: Ordinary Shares · 10,000 shares Expires 2022-05-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F5 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| February 16, 2017 Filed Feb 16, 2017 22:56 UTC |
Ehrich ElliotEVP, R&D & CMO, Alkermes, Inc.
|
SaleOrdinary Shares | 6,085 | $56.84 | $345,853.75 |
DisclosureSEC source: 0001127602-17-006681 · form4.xml · nonDerivative · entry 4 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,657 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $56.56 to $57.18. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| February 16, 2017 Filed Feb 16, 2017 22:56 UTC |
Ehrich ElliotEVP, R&D & CMO, Alkermes, Inc.
|
SaleOrdinary Shares | 3,915 | $56.05 | $219,417.74 |
DisclosureSEC source: 0001127602-17-006681 · form4.xml · nonDerivative · entry 3 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,742 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $55.56 to $56.55. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| February 16, 2017 Filed Feb 16, 2017 22:56 UTC |
Ehrich ElliotEVP, R&D & CMO, Alkermes, Inc.
|
Exercise / conversionOrdinary Shares | 10,000 | $16.55 | $165,500.00 |
DisclosureSEC source: 0001127602-17-006681 · form4.xml · nonDerivative · entry 2 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,657 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| February 15, 2017 Filed Feb 16, 2017 22:56 UTC |
Ehrich ElliotEVP, R&D & CMO, Alkermes, Inc.
|
SaleOrdinary Shares | 1,000 | $58.17 | $58,170.00 |
DisclosureSEC source: 0001127602-17-006681 · form4.xml · nonDerivative · entry 1 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,657 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| February 01, 2017 Filed Feb 2, 2017 23:22 UTC |
MITCHELL PAUL JDirector
|
Exercise / conversionNon Qualified Stock Option (Right to Buy) · Derivative | 1,500 | $0.00 Strike: $11.44 | $0.00 |
DisclosureSEC source: 0001127602-17-003730 · form4.xml · derivative · entry 3 MITCHELL PAUL J · CIK 0001236454 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,000 Underlying: Ordinary Shares · 1,500 shares Expires 2018-10-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| February 01, 2017 Filed Feb 2, 2017 23:22 UTC |
MITCHELL PAUL JDirector
|
SaleOrdinary Shares | 1,500 | $54.45 | $81,675.00 |
DisclosureSEC source: 0001127602-17-003730 · form4.xml · nonDerivative · entry 2 MITCHELL PAUL J · CIK 0001236454 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| February 01, 2017 Filed Feb 2, 2017 23:22 UTC |
MITCHELL PAUL JDirector
|
Exercise / conversionOrdinary Shares | 1,500 | $11.44 | $17,160.00 |
DisclosureSEC source: 0001127602-17-003730 · form4.xml · nonDerivative · entry 1 MITCHELL PAUL J · CIK 0001236454 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,500 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| January 17, 2017 Filed Jan 18, 2017 22:06 UTC |
Ehrich ElliotEVP, R&D & CMO, Alkermes, Inc.
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 10,000 | $0.00 Strike: $16.55 | $0.00 |
DisclosureSEC source: 0001127602-17-001900 · form4.xml · derivative · entry 3 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,801 Underlying: Ordinary Shares · 10,000 shares Expires 2022-05-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| January 17, 2017 Filed Jan 18, 2017 22:06 UTC |
Ehrich ElliotEVP, R&D & CMO, Alkermes, Inc.
|
SaleOrdinary Shares | 11,983 | $54.32 | $650,945.32 |
DisclosureSEC source: 0001127602-17-001900 · form4.xml · nonDerivative · entry 2 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,657 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $54.06 to $54.85. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| January 17, 2017 Filed Jan 18, 2017 22:06 UTC |
Ehrich ElliotEVP, R&D & CMO, Alkermes, Inc.
|
Exercise / conversionOrdinary Shares | 10,000 | $16.55 | $165,500.00 |
DisclosureSEC source: 0001127602-17-001900 · form4.xml · nonDerivative · entry 1 Ehrich Elliot · CIK 0001376548 · EVP, R&D & CMO, Alkermes, Inc. 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,640 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| January 09, 2017 Filed Jan 10, 2017 22:08 UTC |
Stejbach MarkSVP/Chief Comm Off, Alks Inc
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 547 | $0.00 Strike: $17.30 | $0.00 |
DisclosureSEC source: 0001127602-17-001449 · form4.xml · derivative · entry 3 Stejbach Mark · CIK 0001487937 · SVP/Chief Comm Off, Alks Inc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,660 Underlying: Ordinary Shares · 547 shares Expires 2022-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| January 09, 2017 Filed Jan 10, 2017 22:08 UTC |
Stejbach MarkSVP/Chief Comm Off, Alks Inc
|
SaleOrdinary Shares | 547 | $60.27 | $32,967.69 |
DisclosureSEC source: 0001127602-17-001449 · form4.xml · nonDerivative · entry 2 Stejbach Mark · CIK 0001487937 · SVP/Chief Comm Off, Alks Inc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,115 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| January 09, 2017 Filed Jan 10, 2017 22:08 UTC |
Stejbach MarkSVP/Chief Comm Off, Alks Inc
|
Exercise / conversionOrdinary Shares | 547 | $17.30 | $9,463.10 |
DisclosureSEC source: 0001127602-17-001449 · form4.xml · nonDerivative · entry 1 Stejbach Mark · CIK 0001487937 · SVP/Chief Comm Off, Alks Inc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,662 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| January 09, 2017 Filed Jan 10, 2017 22:10 UTC |
Cooke ShanePresident, Alkermes plc
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 550 | $0.00 Strike: $14.60 | $0.00 |
DisclosureSEC source: 0001127602-17-001450 · form4.xml · derivative · entry 3 Cooke Shane · CIK 0001524823 · President, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,000 Underlying: Ordinary Shares · 550 shares Expires 2021-10-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F3 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| January 09, 2017 Filed Jan 10, 2017 22:10 UTC |
Cooke ShanePresident, Alkermes plc
|
SaleOrdinary Shares | 550 | $60.27 | $33,148.50 |
DisclosureSEC source: 0001127602-17-001450 · form4.xml · nonDerivative · entry 2 Cooke Shane · CIK 0001524823 · President, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 63,944 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| January 09, 2017 Filed Jan 10, 2017 22:10 UTC |
Cooke ShanePresident, Alkermes plc
|
Exercise / conversionOrdinary Shares | 550 | $14.60 | $8,030.00 |
DisclosureSEC source: 0001127602-17-001450 · form4.xml · nonDerivative · entry 1 Cooke Shane · CIK 0001524823 · President, Alkermes plc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,494 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
| January 06, 2017 Filed Jan 7, 2017 00:32 UTC |
Stejbach MarkSVP/Chief Comm Off, Alks Inc
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 6,653 | $0.00 Strike: $17.30 | $0.00 |
DisclosureSEC source: 0001127602-17-001311 · form4.xml · derivative · entry 9 Stejbach Mark · CIK 0001487937 · SVP/Chief Comm Off, Alks Inc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,207 Underlying: Ordinary Shares · 6,653 shares Expires 2022-03-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F6 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| January 06, 2017 Filed Jan 7, 2017 00:32 UTC |
Stejbach MarkSVP/Chief Comm Off, Alks Inc
|
SaleOrdinary Shares | 6,653 | $60.07 | $399,643.05 |
DisclosureSEC source: 0001127602-17-001311 · form4.xml · nonDerivative · entry 6 Stejbach Mark · CIK 0001487937 · SVP/Chief Comm Off, Alks Inc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,115 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F5 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $60.00 to $60.41. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request. Read SEC document |
| January 06, 2017 Filed Jan 7, 2017 00:32 UTC |
Stejbach MarkSVP/Chief Comm Off, Alks Inc
|
Exercise / conversionOrdinary Shares | 6,653 | $17.30 | $115,096.90 |
DisclosureSEC source: 0001127602-17-001311 · form4.xml · nonDerivative · entry 5 Stejbach Mark · CIK 0001487937 · SVP/Chief Comm Off, Alks Inc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,768 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.